Article Versions Notes

Geisler A, Dieringer B, Elsner L, Girod M, Van Linthout S, Kurreck J, Fechner H. Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3. International Journal of Molecular Sciences. 2025; 26(14):6877. https://doi.org/10.3390/ijms26146877

Geisler, Anja, Babette Dieringer, Leslie Elsner, Maxim Girod, Sophie Van Linthout, Jens Kurreck, and Henry Fechner. 2025. "Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3" International Journal of Molecular Sciences 26, no. 14: 6877. https://doi.org/10.3390/ijms26146877

Geisler, A., Dieringer, B., Elsner, L., Girod, M., Van Linthout, S., Kurreck, J., & Fechner, H. (2025). Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3. International Journal of Molecular Sciences, 26(14), 6877. https://doi.org/10.3390/ijms26146877